Intratect

Human Normal Immunoglobulin, the active ingredient in Intratect, is an Immunoglobulin (human) presented as an intravenous solution for intravenous use. It provides passive immunity for patients with primary or secondary immunodeficiency, Kawasaki disease, and immune thrombocytopenic purpura. GNH USA supplies Intratect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Intratect, a human immunoglobulin therapy, is used to replace deficient antibodies in various immune‑mediated conditions.

Primary immunodeficiency diseases: restores normal antibody levels to reduce infection risk. Secondary immunodeficiency: provides passive immunity to patients with acquired antibody deficiencies. Kawasaki disease: reduces inflammation and coronary artery complications in the acute phase. Immune thrombocytopenic purpura (ITP): modulates immune response to increase platelet counts.

Common Side Effects: - Headache - Fever or chills - Nausea - Fatigue - Infusion‑related erythema or itching - Mild hypotension

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reaction - Aseptic meningitis - Hemolytic anemia - Thromboembolic events - Renal dysfunction - Severe thrombocytopenia

Precautions for Intratect include: - Screen for IgA deficiency: avoid in patients with anti‑IgA antibodies. - Monitor for infection: assess clinical response and signs of new infection. - Assess renal function: adjust infusion in patients with renal impairment. - Avoid concurrent live vaccines: immunoglobulin may neutralize vaccine efficacy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intratect may interact with other agents as follows:

Major Interactions (Avoid): - Live vaccines: immunoglobulin can neutralize vaccine efficacy. - Blood products: may interfere with serologic testing. - Immunosuppressants: may increase infection risk when combined.

Moderate Interactions (Monitor Closely): - Anticoagulants: may affect coagulation parameters. - Corticosteroids: may mask signs of infection. - Inactivated vaccines: may have reduced immunogenicity.